Warning Letter Blasts Sri Krishna Over Data Integrity Concerns

Drug Industry Daily
A A
A second FDA inspection of niche drugmaker Sri Krishna in almost 10 years has turned up a bevy of complaints regarding the company’s quality control systems and the accuracy of its data.

To View This Article:

Login

Subscribe To Drug Industry Daily